PT  - JOURNAL ARTICLE
AU  - George A. Margaritopoulos
AU  - Eirini Vasarmidi
AU  - Joseph Jacob
AU  - Athol U. Wells
AU  - Katerina M. Antoniou
TI  - Smoking and interstitial lung diseases
AID  - 10.1183/16000617.0050-2015
DP  - 2015 Sep 01
TA  - European Respiratory Review
PG  - 428--435
VI  - 24
IP  - 137
4099  - http://err.ersjournals.com/content/24/137/428.short
4100  - http://err.ersjournals.com/content/24/137/428.full
SO  - EUROPEAN RESPIRATORY REVIEW2015 Sep 01; 24
AB  - For many years has been well known that smoking could cause lung damage. Chronic obstructive pulmonary disease and lung cancer have been the two most common smoking-related lung diseases. In the recent years, attention has also focused on the role of smoking in the development of interstitial lung diseases (ILDs). Indeed, there are three diseases, namely respiratory bronchiolitis-associated ILD, desquamative interstitial pneumonia and pulmonary Langerhans cell histiocytosis, that are currently considered aetiologically linked to smoking and a few others which are more likely to develop in smokers. Here, we aim to focus on the most recent findings regarding the role of smoking in the pathogenesis and clinical behaviour of ILDs.Smoking is implicated in the pathogenesis and clinical behaviour of interstitial lung disease http://ow.ly/PYLcT